In change of tack, EU leaves door open to COVID vaccines purchase through WHO

FILE PHOTO: A woman holds a small bottle labelled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

That would represent a change of policy after the EU executive had advised the 27 EU governments not to purchase vaccines through the WHO scheme deeming it slow, expensive and legally incompatible with the parallel EU procurement programme, EU officials said in July. By forcing EU states to buy only through an EU scheme, the Commission could reduce the limited amount of doses initially available to less developed countries, because it would prioritise the 450 million EU citizens, effectively replicating nationalist policies of the United States and other countries critical of the WHO initiative.

They are also allowed to conduct parallel talks if they decide to opt-out from deals signed by the EU Commission. When Germany, France, Italy and the Netherlands signed a preliminary deal with AstraZeneca in June over its potential vaccine, many EU governments complained of having been sidetracked, even if they were in theory offered access to doses.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

France new COVID-19 infections down but hospitalisations upFrench health authorities reported 3,082 new COVID-19 infections over the past 24 hours, sharply down from a caseload of above 5,000 each on the two previous days, but the Monday figure always tends to dip as there are less tests conducted on Sundays. all ready for maniupted market again , and life The number of new cases matters not! With a recovery rate in excess of 99.99%, the vast majority will have few, if any symptoms at all! This fear mongering bullshit must be stopped! Plandemic Agenda21 ID2020 Operationlockstep Quantumtattoo Coronavirus Covid19
Source: Reuters - 🏆 2. / 97 Read more »